Cargando…
Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286879/ https://www.ncbi.nlm.nih.gov/pubmed/34295472 http://dx.doi.org/10.1002/cti2.1317 |
| _version_ | 1783723805239148544 |
|---|---|
| author | Abbott, Rebecca C Verdon, Daniel J Gracey, Fiona M Hughes‐Parry, Hannah E Iliopoulos, Melinda Watson, Katherine A Mulazzani, Matthias Luong, Kylie D’Arcy, Colleen Sullivan, Lucy C Kiefel, Ben R Cross, Ryan S Jenkins, Misty R |
| author_facet | Abbott, Rebecca C Verdon, Daniel J Gracey, Fiona M Hughes‐Parry, Hannah E Iliopoulos, Melinda Watson, Katherine A Mulazzani, Matthias Luong, Kylie D’Arcy, Colleen Sullivan, Lucy C Kiefel, Ben R Cross, Ryan S Jenkins, Misty R |
| author_sort | Abbott, Rebecca C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8286879 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82868792021-07-21 Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma Abbott, Rebecca C Verdon, Daniel J Gracey, Fiona M Hughes‐Parry, Hannah E Iliopoulos, Melinda Watson, Katherine A Mulazzani, Matthias Luong, Kylie D’Arcy, Colleen Sullivan, Lucy C Kiefel, Ben R Cross, Ryan S Jenkins, Misty R Clin Transl Immunology Corrigendum John Wiley and Sons Inc. 2021-07-18 /pmc/articles/PMC8286879/ /pubmed/34295472 http://dx.doi.org/10.1002/cti2.1317 Text en © 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigendum Abbott, Rebecca C Verdon, Daniel J Gracey, Fiona M Hughes‐Parry, Hannah E Iliopoulos, Melinda Watson, Katherine A Mulazzani, Matthias Luong, Kylie D’Arcy, Colleen Sullivan, Lucy C Kiefel, Ben R Cross, Ryan S Jenkins, Misty R Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma |
| title | Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma |
| title_full | Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma |
| title_fullStr | Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma |
| title_full_unstemmed | Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma |
| title_short | Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma |
| title_sort | novel high‐affinity egfrviii‐specific chimeric antigen receptor t cells effectively eliminate human glioblastoma |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286879/ https://www.ncbi.nlm.nih.gov/pubmed/34295472 http://dx.doi.org/10.1002/cti2.1317 |
| work_keys_str_mv | AT abbottrebeccac novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT verdondanielj novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT graceyfionam novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT hughesparryhannahe novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT iliopoulosmelinda novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT watsonkatherinea novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT mulazzanimatthias novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT luongkylie novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT darcycolleen novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT sullivanlucyc novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT kiefelbenr novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT crossryans novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma AT jenkinsmistyr novelhighaffinityegfrviiispecificchimericantigenreceptortcellseffectivelyeliminatehumanglioblastoma |